Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CYP3A5 Genotype as a Potential Risk Factor for the Development of Ifosamide Nephrotoxicity in Children

NCT00514345 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00514345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00514345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CYP3A5 Genotype as a Potential Risk Factor for the Development of Ifosamide Nephrotoxicity in Children
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2007
Completion date
Not reported
Enrollment
300 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic agent toxicity, sarcoma, unspecified childhood solid tumor, protocol specific